Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000502392 | SCV000594581 | pathogenic | Cockayne syndrome type 2 | 2016-08-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001246953 | SCV001420348 | pathogenic | not provided | 2024-03-12 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg975*) in the ERCC6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ERCC6 are known to be pathogenic (PMID: 18628313, 29572252). This variant is present in population databases (rs772801089, gnomAD 0.004%). This premature translational stop signal has been observed in individuals with Cockayne syndrome (PMID: 28440418, 29572252; Invitae). ClinVar contains an entry for this variant (Variation ID: 435082). For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV001246953 | SCV004022831 | pathogenic | not provided | 2024-11-27 | criteria provided, single submitter | clinical testing | Reported in a individual with Cockayne syndrome who also harbored another variant in the ERCC6 gene in published literature (PMID: 29572252); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 28440418, 29572252) |